betPawa ranks first in Acquisition Power Score among iGaming brands in regulated markets for 2024
February 12, 2025 | Company
According to the latest study by Blask, the AI-driven iGaming analytics ecosystem, betPawa’s total Acquisition...
Read more >
Positive Phase 2 trial readout for long-term efficacy & safety of denovoSkin™ in reconstructive skin surgery and in burns
| Company
CUTISS announced positive long-term efficacy and safety readout in the Phase 2 clinical trials of denovoSkin™ ...
Read more >
Nvidia, AMD and Intel Invest in Startup Bringing Light to Chips
December 11, 2024 | Company
Ayar Labs Inc., which specializes in using light to transfer data between chips, scored investment from the thre...
Read more >
EMA authorizes Phase 3 clinical trial for denovoSkin™
December 3, 2024 | Company
CUTISS has received authorization from the European Medicines Agency (EMA) to commence the Phase 3 clinical tria...
Read more >
Immunophotonics Announces 1st Patient Dosed in a Randomised Phase 2 Study at the University of Louisville
August 15, 2024 | Company
Immunophotonics, Inc., in collaboration with Dr. Robert CG Martin II, M.D, PhD, FACS, who serves as the Principa...
Read more >
SkyCell closes US$116 million Series D
June 25, 2024 | Company
SkyCell has successfully closed a $116 million Series D funding round. This investment will be used for the cont...
Read more >